Khushbu Chaudhari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khushbu Chaudhari has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Harsh Shah
Department of Pharmaceutical Sciences, Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, NY, USA
1 shared publicationJigisha Patadia
Government Medical College Surat, Gujarat, India
1 shared publication- Jignasa K. Savjani
Department of Pharmaceutical Chemistry, Institute of Pharmacy, Nirma University, Ahmedabad, India
1 shared publication - Ketan T. Savjani
Emcure Pharmaceuticals, Gandhinagar, India
1 shared publication - Ravindra Kamble
Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune, Maharashtra, India
1 shared publication Shailendra Khasavat
Government Medical College Surat, Gujarat, India
1 shared publication
Latest Publications
- Open Access
- 15 November 2023
- Published by IP Innovative Publication Pvt Ltd in IP International Journal of Medical Paediatrics and Oncology
- Vol. 9 (3) , 87-91
Study prognostic significance of low platelet count in newborn admitted in neonatal intensive care unit (NICU) at tertiary care center
Study prognostic significance of low platelet count in newborn admitted in neonatal intensive care unit (NICU) at tertiary care center - IJMPO- Print ISSN No: - 2581-4699 Online ISSN No:- 2581-4702 Article DOI No:- 10.18231/j.ijmpo.2023.018, IP International Journal of Medical Paediatrics and Oncology-IP Int J Med Paed
- 15 November 2023
- Published by IP Innovative Publication Pvt Ltd in IP International Journal of Medical Paediatrics and Oncology
- Vol. 9 (3) , 87-91
Open AccessStudy prognostic significance of low platelet count in newborn admitted in neonatal intensive care unit (NICU) at tertiary care center
Study prognostic significance of low platelet count in newborn admitted in neonatal intensive care unit (NICU) at tertiary care center - IJMPO- Print ISSN No: - 2581-4699 Online ISSN No:- 2581-4702 Article DOI No:- 10.18231/j.ijmpo.2023.018, IP International Journal of Medical Paediatrics and Oncology-IP Int J Med Paed
- 3 October 2021
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 47 (10) , 1633-1642
Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method
Ritonavir is a BCS class II antiretroviral agent which shows poor aqueous solubility and low oral bioavailability. The cocrystallization approach was selected to overcome these problems and to improve the physicochemical and mechanical properties of Ritonavir. The novel pharmaceutical Ritonavir-L-tyrosine cocrystals (RTC at a molar ratio of 1:1) were synthesized using the liquid assisted grinding (LAG) method. The possibility of molecular interactions between drug and coformer were studied using Gold software version 5.2. The newly formed crystalline solid phase was characterized through Differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), Fourier transform-infrared spectroscopy (FT-IR), Scanning electron microscopy (SEM), and Solid-State Nuclear magnetic resonance (SSNMR). The improved pharmaceutical properties were confirmed by solubility, dissolution, and powder compaction study. The prepared cocrystals exhibited an 11.24-fold increase in solubility and a 3.73-fold increase in % of drug release at 1 h compared to pure drug. Tabletability and compaction behaviour of the pure drug and cocrystal with added excipients assessed. The tabletability profile of cocrystals showed enhanced tabletting performance as compared to pure drug. The stability studies revealed that cocrystals were stable for at least one month when stored at 40 °C/75% RH and 25 °C/60% RH conditions. The cocrystallization approach was found to be very promising and showed an overall improved performance of Ritonavir.
- 3 October 2021
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 47 (10) , 1633-1642
Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method
Ritonavir is a BCS class II antiretroviral agent which shows poor aqueous solubility and low oral bioavailability. The cocrystallization approach was selected to overcome these problems and to improve the physicochemical and mechanical properties of Ritonavir. The novel pharmaceutical Ritonavir-L-tyrosine cocrystals (RTC at a molar ratio of 1:1) were synthesized using the liquid assisted grinding (LAG) method. The possibility of molecular interactions between drug and coformer were studied using Gold software version 5.2. The newly formed crystalline solid phase was characterized through Differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), Fourier transform-infrared spectroscopy (FT-IR), Scanning electron microscopy (SEM), and Solid-State Nuclear magnetic resonance (SSNMR). The improved pharmaceutical properties were confirmed by solubility, dissolution, and powder compaction study. The prepared cocrystals exhibited an 11.24-fold increase in solubility and a 3.73-fold increase in % of drug release at 1 h compared to pure drug. Tabletability and compaction behaviour of the pure drug and cocrystal with added excipients assessed. The tabletability profile of cocrystals showed enhanced tabletting performance as compared to pure drug. The stability studies revealed that cocrystals were stable for at least one month when stored at 40 °C/75% RH and 25 °C/60% RH conditions. The cocrystallization approach was found to be very promising and showed an overall improved performance of Ritonavir.
- Open Access
- 1 January 2018
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 30 (1) , 138-141
Electrospray technique for cocrystallization of phytomolecules
Poor aqueous solubility of most of the phytomolecules has restricted their vital biological use. Cocrystal approach can be one of the remedies for the problem. The present work was carried out with an objective to screen the potential of electrospray technique towards cocrystallization of quercetin (QUE). QUE was cocrystallized with caffeine (CAF) and nicotinamide (NIC) as coformers. Saturated methanolic solutions of QUE with either of the coformers (CAF and NIC) in 1:1 ratio were electrosprayed at 40 °C. The technique was successfully used for cocrystallization of QUE with CAF and NIC separately as revealed by Powder X-ray Diffraction, Differential scanning calorimetry and Fourier transform infrared spectroscopy studies. Additionally, the results of saturation solubility study suggested 14 and 11 folds increase in solubility of QUE upon its cocrystallization with CAF and NIC respectively. Herein we propose a new technique for cocrystallization and in turn resolving solubility issues of phytomolecules which can be an alternative to the existing cocrystallisation techniques
- 1 January 2018
- Published by Scientific Scholar in Journal of King Saud University – Science
- Vol. 30 (1) , 138-141
Open AccessElectrospray technique for cocrystallization of phytomolecules
Poor aqueous solubility of most of the phytomolecules has restricted their vital biological use. Cocrystal approach can be one of the remedies for the problem. The present work was carried out with an objective to screen the potential of electrospray technique towards cocrystallization of quercetin (QUE). QUE was cocrystallized with caffeine (CAF) and nicotinamide (NIC) as coformers. Saturated methanolic solutions of QUE with either of the coformers (CAF and NIC) in 1:1 ratio were electrosprayed at 40 °C. The technique was successfully used for cocrystallization of QUE with CAF and NIC separately as revealed by Powder X-ray Diffraction, Differential scanning calorimetry and Fourier transform infrared spectroscopy studies. Additionally, the results of saturation solubility study suggested 14 and 11 folds increase in solubility of QUE upon its cocrystallization with CAF and NIC respectively. Herein we propose a new technique for cocrystallization and in turn resolving solubility issues of phytomolecules which can be an alternative to the existing cocrystallisation techniques